Cargando…
Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells
Despite recent advances in clinical stem cell therapy applications based on human pluripotent stem cells (hPSCs), potential teratoma formation due to the presence of residual undifferentiated hPSCs remains a serious risk factor that challenges widespread clinical application. To overcome this risk,...
Autores principales: | Go, Young-Hyun, Kim, Jumee, Jeong, Ho-Chang, Kim, Seong-Min, Kim, Yun-Jeong, Park, Soon-Jung, Moon, Sung-Hwan, Cha, Hyuk-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692041/ https://www.ncbi.nlm.nih.gov/pubmed/33121085 http://dx.doi.org/10.3390/biomedicines8110453 |
Ejemplares similares
-
Structure-Activity Relationship Analysis of YM155 for Inducing Selective Cell Death of Human Pluripotent Stem Cells
por: Go, Young-Hyun, et al.
Publicado: (2019) -
Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity
por: Cho, Seung-Ju, et al.
Publicado: (2015) -
Dichotomous role of Shp2 for naïve and primed pluripotency maintenance in embryonic stem cells
por: Kim, Seong-Min, et al.
Publicado: (2022) -
High expression of uracil DNA glycosylase determines C to T substitution in human pluripotent stem cells
por: Park, Ju-Chan, et al.
Publicado: (2021) -
MutSα and MutSβ as size-dependent cellular determinants for prime editing in human embryonic stem cells
por: Park, Ju-Chan, et al.
Publicado: (2023)